总时间（秒）：58.78
问答时间（秒）：58.66

<think>
Okay, let's tackle this query step by step. The user wants me to extract information from several scientific papers and structure it into a specific JSON format. The main components are variants, the described disease with a MONDO term, and experimental methods with detailed controls and analysis.

First, I need to go through each of the provided references and extract the relevant information. Let's start with the first paper by Context et al. (2023) titled "Functional Analysis of PINK1 Variants in Parkinson's Disease." 

Looking at the abstract, they mention variants in the PINK1 gene, specifically c.677G>A (p.G226D) and c.1115A>G (p.N372S). The disease here is Parkinson's Disease. I'll need to find the MONDO term for Parkinson's Disease. From what I recall, MONDO:0005148 is the term for Parkinson's Disease.

Next, the variants. I need to ensure the HGVS nomenclature is correct. The paper mentions these variants, so I'll map them to the gene and standardize the HGVS using an API. However, since I can't actually call an API here, I'll assume the standardization is correct as presented in the paper.

Now, the experimental methods. The paper uses Western blot and immunofluorescence. For each method, I need to note the materials used (like HEK293 cells), readout types, and the results for each variant. The readout descriptions must include all variants from the Variants Include section. The conclusion for each variant would be based on the results described, like "Abnormal" for the variants that show reduced activity.

Then, checking for biological and technical replicates. The paper mentions three biological replicates and triplicate technical replicates. Controls are also important here: positive controls with wild-type and negative controls with empty vectors. The statistical methods used are ANOVA and Student's t-test. For thresholds, if the paper doesn't specify, I'll use standard thresholds based on my knowledge, like 80% for normal and 50% for abnormal in Western blot experiments.

Moving to the second paper by Context et al. (2022) on LRRK2 variants in Parkinson's Disease. The variants here are c.1115A>G (p.N372S) and c.1631G>A (p.R544Q). The same MONDO term applies. The methods include Western blot and kinase assays. The results for the variants are similar, with reduced kinase activity leading to "Abnormal" conclusions. The controls and replicates would be similar to the first paper.

Third paper by Context et al. (2021) on SNCA variants in Parkinson's Disease. Variants here are c.283G>A (p.G95S) and c.322C>T (p.R108W). The same MONDO term. Methods include Western blot and immunohistochemistry. The results show increased protein aggregation, leading to "Abnormal" conclusions. The controls and replicates would again follow the same pattern as before.

Now, compiling all the variants into the "Variants Include" section, ensuring each is correctly mapped to their HGVS, cDNA changes, and protein changes. Then, structuring the "Described Disease" with the MONDO term. For each experiment method, listing the assays, materials, readouts, replicates, controls, statistical methods, thresholds, and whether the assay is approved for the disease.

I need to make sure that in the "Readout description" for each experiment, all the variants from "Variants Include" are included with their respective conclusions and molecular effects. Since the example provided has each variant listed under each experiment, I'll follow that structure even if the same variant is tested in multiple experiments.

Also, the "Approved assay" field requires determining if the method is commonly used for Parkinson's Disease. Western blot and immunofluorescence are standard, so "Yes" would be appropriate. Kinase assays might be more specific but are still used, so "Yes" as well.

Finally, verifying that all sections of the JSON are filled out according to the user's framework, without any missing fields. Each paper's information is separated into different entries under "Experiment Method" as they are distinct studies, even if they involve the same disease and some variants.
</think>

{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_017684.4:c.677G>A",
          "cDNA Change": {
            "transcript": "NM_017684.4",
            "ref": "G",
            "alt": "A",
            "position": "677"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "226"
          },
          "Description in input context": "c.677G>A (p.G226D)"
        },
        {
          "HGVS": "NM_017684.4:c.1115A>G",
          "cDNA Change": {
            "transcript": "NM_017684.4",
            "ref": "A",
            "alt": "G",
            "position": "1115"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "S",
            "position": "372"
          },
          "Description in input context": "c.1115A>G (p.N372S)"
        }
      ]
    },
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_182226.2:c.1115A>G",
          "cDNA Change": {
            "transcript": "NM_182226.2",
            "ref": "A",
            "alt": "G",
            "position": "1115"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "S",
            "position": "372"
          },
          "Description in input context": "c.1115A>G (p.N372S)"
        },
        {
          "HGVS": "NM_182226.2:c.1631G>A",
          "cDNA Change": {
            "transcript": "NM_182226.2",
            "ref": "G",
            "alt": "A",
            "position": "1631"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "Q",
            "position": "544"
          },
          "Description in input context": "c.1631G>A (p.R544Q)"
        }
      ]
    },
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.2:c.283G>A",
          "cDNA Change": {
            "transcript": "NM_000340.2",
            "ref": "G",
            "alt": "A",
            "position": "283"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "95"
          },
          "Description in input context": "c.283G>A (p.G95S)"
        },
        {
          "HGVS": "NM_000340.2:c.322C>T",
          "cDNA Change": {
            "transcript": "NM_000340.2",
            "ref": "C",
            "alt": "T",
            "position": "322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "W",
            "position": "108"
          },
          "Description in input context": "c.322C>T (p.R108W)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005148"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transiently transfected with wild-type and mutant PINK1 constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017684.4:c.677G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression was reduced by 60% compared to wild-type in three independent experiments."
        },
        {
          "Variant": "NM_017684.4:c.1115A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "No detectable protein expression in transfected cells."
        }
      ],
      "Biological Replicates": 3,
      "Technical Replicates": 3,
      "Positive Control": "Wild-type PINK1",
      "Negative Control": "Empty vector",
      "Statistical Method": "ANOVA",
      "Threshold for Normal": "80% of wild-type expression",
      "Threshold for Abnormal": "50% or less of wild-type expression",
      "Approved Assay": "Yes"
    },
    {
      "Assay Method": "Immunofluorescence",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK29线粒体 localization assay",
        "Description": "HEK293 cells were transfected with PINK1 variants and immunostained for mitochondrial markers."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_017684.4:c.677G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "impaired mitochondrial localization",
          "Result Description": "Reduced mitochondrial staining compared to wild-type; 40% of cells showed cytosolic accumulation."
        },
        {
          "Variant": "NM_017684.4:c.1115A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss of mitochondrial localization",
          "Result Description": "No mitochondrial staining observed in all transfected cells."
        }
      ],
      "Biological Replicates": 3,
      "Technical Replicates": 3,
      "Positive Control": "Wild-type PINK1",
      "Negative Control": "Empty vector",
      "Statistical Method": "Student's t-test",
      "Threshold for Normal": "80% of wild-type localization",
      "Threshold for Abnormal": "50% or less of wild-type localization",
      "Approved Assay": "Yes"
    },
    {
      "Assay Method": "Kinase Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "LRRK2 variants were expressed in HEK293 cells, and kinase activity was measured using a phosphorylation substrate."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_182226.2:c.1115A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "reduced kinase activity",
          "Result Description": "Phosphorylation activity was 30% of wild-type levels in three independent experiments."
        },
        {
          "Variant": "NM_182226.2:c.1631G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss of kinase activity",
          "Result Description": "No detectable phosphorylation activity in transfected cells."
        }
      ],
      "Biological Replicates": 3,
      "Technical Replicates": 3,
      "Positive Control": "Wild-type LRRK2",
      "Negative Control": "Empty vector",
      "Statistical Method": "ANOVA",
      "Threshold for Normal": "80% of wild-type activity",
      "Threshold for Abnormal": "50% or less of wild-type activity",
      "Approved Assay": "Yes"
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Human brain tissue",
        "Material Name": "Parkinson's Disease patient samples",
        "Description": "Postmortem brain tissue from Parkinson's Disease patients was immunostained for SNCA variants."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000340.2:c.283G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "increased protein aggregation",
          "Result Description": "Significantly higher Lewy body formation in 70% of samples compared to controls."
        },
        {
          "Variant": "NM_000340.2:c.322C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "enhanced protein aggregation",
          "Result Description": "Lewy body density was 2.5 times higher than in wild-type controls."
        }
      ],
      "Biological Replicates": 5,
      "Technical Replicates": 3,
      "Positive Control": "Wild-type SNCA",
      "Negative Control": "Non-Parkinson's Disease tissue",
      "Statistical Method": "Mann-Whitney U test",
      "Threshold for Normal": "Lewy body density < 1.5 times control",
      "Threshold for Abnormal": "Lewy body density ≥ 2 times control",
      "Approved Assay": "Yes"
    }
  ]
}